Gujarat Inject (Kerala) Ltd
₹ 19.1
4.37%
12 Nov
- close price
About
Incorporated in 1991, Gujarat Inject Kerala Ltd manufactures pharmaceutical products
Key Points
- Market Cap ₹ 28.0 Cr.
- Current Price ₹ 19.1
- High / Low ₹ 19.5 / 8.35
- Stock P/E 36.3
- Book Value ₹ 6.64
- Dividend Yield 0.00 %
- ROCE 4.06 %
- ROE 3.33 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 2.88 times its book value
- Working capital days have increased from -1,540 days to 167 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.33 | -0.00 | -0.00 | 0.02 | 1.57 | -0.00 | -0.00 | -0.00 | 0.01 | 0.02 | 0.17 | 5.79 | 17.30 | |
| 2.26 | -0.00 | -0.00 | 0.02 | 1.56 | 0.07 | 0.03 | 0.01 | 0.13 | 0.07 | 0.54 | 5.74 | 16.57 | |
| Operating Profit | 0.07 | -0.00 | -0.00 | -0.00 | 0.01 | -0.07 | -0.03 | -0.01 | -0.12 | -0.05 | -0.37 | 0.05 | 0.73 |
| OPM % | 3.00% | -0.00% | 0.64% | -1,200.00% | -250.00% | -217.65% | 0.86% | 4.22% | |||||
| 0.12 | -0.00 | -0.00 | 2.30 | -0.00 | 0.05 | 0.02 | 0.01 | 0.01 | 0.05 | 0.43 | 0.06 | 0.21 | |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Depreciation | 0.48 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Profit before tax | -0.29 | -0.00 | -0.00 | 2.30 | 0.01 | -0.02 | -0.01 | -0.00 | -0.11 | -0.00 | 0.06 | 0.11 | 0.94 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 16.67% | 18.18% | |||||
| -0.29 | -0.00 | -0.00 | 2.30 | 0.01 | -0.02 | -0.01 | -0.00 | -0.11 | -0.00 | 0.04 | 0.08 | 0.77 | |
| EPS in Rs | -0.59 | -0.00 | -0.00 | 4.69 | 0.02 | -0.04 | -0.02 | -0.00 | -0.22 | -0.00 | 0.08 | 0.07 | 0.54 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 733% |
| TTM: | 6820% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 58% |
| 3 Years: | 40% |
| TTM: | 1440% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 109% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 3% |
Balance Sheet
Figures in Rs. Crores
| Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 11.29 | 14.63 |
| Reserves | -23.13 | -7.64 | -7.95 | -5.64 | -5.64 | -5.66 | -5.66 | -5.66 | -5.77 | -5.76 | -5.72 | -5.64 | -4.91 |
| 23.89 | 2.55 | 2.86 | 0.56 | 0.57 | 0.59 | 0.59 | 0.59 | 0.69 | 0.73 | 0.61 | -0.00 | -0.00 | |
| 0.54 | 0.38 | 0.38 | 0.36 | 0.20 | 0.21 | 0.20 | 0.20 | 0.22 | 0.22 | 0.53 | 3.04 | 4.51 | |
| Total Liabilities | 6.18 | 0.17 | 0.17 | 0.16 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 | 14.23 |
| 5.29 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| 0.89 | 0.17 | 0.17 | 0.16 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 | 14.23 | |
| Total Assets | 6.18 | 0.17 | 0.17 | 0.16 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 | 14.23 |
Cash Flows
Figures in Rs. Crores
| Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.11 | -0.00 | 0.05 | -5.83 | |
| -0.03 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.10 | -0.00 | -0.00 | 8.69 | |
| Net Cash Flow | -0.03 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | 0.05 | 2.86 |
Ratios
Figures in Rs. Crores
| Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40.73 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Inventory Days | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 40.73 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Working Capital Days | 50.13 | -3,832.50 | -48.82 | -7,300.00 | -3,650.00 | -1,137.94 | 167.06 | |||||
| ROCE % | -5.01% | 4.06% |
Documents
Announcements
- Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On September 30, 2024 Along With Limited Review Report (Unmodified Opinion) 22 Oct
-
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On October 22, 2024
22 Oct - Approved unaudited financial results for Q2 FY2024.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Oct - Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended September 30, 2024
-
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Tuesday, October 22, 2024
7 Oct - Board meeting scheduled for October 22, 2024.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 28 Sep
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2011
from bse
-
Financial Year 2007
from bse
-
Financial Year 2005
from bse
-
Financial Year 2004
from bse
-
Financial Year 2003
from bse
Business Overview:[1]
Company is jointly promoted by Kerala State Industrial Development Corporation Limited,
a wholly owned subsidiary of Government of Kerala and Gujarat Inject Limited. Company manufactures and sells bulk drugs, formulations, chemicals, medicinal preparation, intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipment viz., disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes, diagnostic kits, etc.